Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Ardelyx licenses NaPi-2b phosphate inhibitor program to Sanofi

Feb. 25, 2014

Dosing completed in phase II trial of GCS-100 for chronic kidney disease

Feb. 24, 2014

Regulus Therapeutics nominates RG-012 as candidate for Alport syndrome

Feb. 21, 2014

Japanese researchers claim new prostanoid EP1 receptor antagonists

Feb. 17, 2014

Astellas reports melatonin agonists for urinary incontinence

Jan. 29, 2014

Japan Tobacco and Torii gain approval for Riona Tablets in Japan

Jan. 17, 2014

Extended treatment phase of ZS-9 phase III trial in hyperkalemia meets endpoint

Jan. 15, 2014

Proteon obtains E.U. orphan drug status for PRT-201 for hemodialysis vascular access

Jan. 10, 2014

Development and characterization of an orally available antifibrotic drug to treat renal fibrosis

Jan. 2, 2014

Novel autotaxin inhibitors synthesized by Roche

Dec. 31, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
XPC-837 restores network dysfunction in Dravet syndrome models
BioWorld Science
Researchers from Xenon Pharmaceuticals Inc. described the preclinical efficacy of XPC-837 in models of Dravet syndrome, a severe developmental and epileptic...